Information on new approvals and medication safety that rheumatologists need to know
Search results for: cardiovascular
2013 ACR/ARHP Annual Meeting: Diagnostic,Treatment Approaches Evolve for Kawasaki Disease
New data examine infliximab as a treatment option, and updated diagnostic criteria aids physicians in recognizing KD and detecting cardiac involvement in patients
Why Antiphospholipid Antibody Syndrome Should Be On Your Radar
With a wide range of clinical manifestations and frequent occurrence among rheumatology patients, APS is one for rheumatologists to watch
Rheuminations: Why the Obesity Epidemic Should Matter to Rheumatologists
As changes in diet and eating habits have caused obesity rates to soar, research into the metabolic syndrome suggests obesity may be a form of a low-grade inflammatory state
Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life
Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus
2013 ACR/ARHP Annual Meeting: Rheumatologists In the Spotlight
ACR members honored with awards for service, research, and mentorship in rheumatology
Genetic Link Between Cellular Cholesterol Homeostasis and Energy Metabolism
A new study suggests that GATM may serve as the functional link between the ability of statins to lower cholesterol and their ability to cause statin-induced myopathy. (posted Nov. 19)
What Diet to Recommend to Patients with Rheumatoid Arthritis?
With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis
The Dietitian’s Role in Managing Rheumatology Patients
How dietary experts can help a multidisciplinary healthcare team by educating patients on nutrition and their health
Study Points to Need for Increased Antirheumatic Therapy in Patients with Dyslipidemia
A new study suggests that patients diagnosed with RA as well as dyslipidemia may benefit from more aggressive antirheumatic therapy. (posted Oct. 3, 2013)
- « Previous Page
- 1
- …
- 50
- 51
- 52
- 53
- 54
- …
- 65
- Next Page »